Patents by Inventor Annerose Mauz

Annerose Mauz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6828311
    Abstract: The invention relates to a new formulation containing Bill 890 or one of the pharmaceutically acceptable salts thereof for parenteral administration.
    Type: Grant
    Filed: May 28, 2003
    Date of Patent: December 7, 2004
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Bernd Kruss, Annerose Mauz, Karin Ruehr, Jean Marie Stassen, Claus Veit, Klaus Wagner
  • Publication number: 20040019013
    Abstract: The invention relates to a new formulation containing BIII 890 or one of the pharmaceutically acceptable salts thereof for parenteral administration.
    Type: Application
    Filed: May 28, 2003
    Publication date: January 29, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
    Inventors: Bernd Kruss, Annerose Mauz, Karin Ruehr, Jean-Marie Stassen, Claus Veit, Klaus Wagner
  • Publication number: 20030235576
    Abstract: The invention relates to new drug combinations based on sodium channel blockers 1 and fibrinolytics 2, processes for the preparation thereof as well as the use thereof for preparing pharmaceutical compositions for the treatment of ischaemic conditions.
    Type: Application
    Filed: June 12, 2003
    Publication date: December 25, 2003
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Hermann Duettmann, Annerose Mauz, Sophie Banzet
  • Patent number: 5618814
    Abstract: The invention relates to trisubstituted pyrimido [5,4-d]-pyrimidines of general formula ##STR1## (wherein R.sub.a, R.sub.b and R.sub.c are defined as in claim 1) and the salts thereof, more particularly for pharmaceutical use the physiologically acceptable salts thereof, which have, inter alia, valuable pharmacological properties, particularly in chemotherapy a sensitizing effect on resistant tumors, the use thereof and processes for preparing them.
    Type: Grant
    Filed: August 2, 1994
    Date of Patent: April 8, 1997
    Assignee: Dr. Karl Thomae GmbH
    Inventors: Armin Heckel, Uwe Bamberger, Annerose Mauz
  • Patent number: 5135932
    Abstract: The invention relates to new 2-hydroxy-n-propylamines of the formulaR.sub.1 --O--CH.sub.2 --CHOH--CH.sub.2 --NH--A--R.sub.2 (I)whereinR.sub.1, R.sub.2 and A are defined as in claim 1, the tautomers, enantiomers and acid addition salts thereof, particularly for pharmaceutical use the physiologically acceptable acid addition salts thereof with inorganic or organic acids, which have valuable pharmacological properties, more particularly a simultaneous cardiotonic and .beta.-blocking activity, and the use thereof as pharmaceutical compositions and processes for preparing them.
    Type: Grant
    Filed: May 30, 1990
    Date of Patent: August 4, 1992
    Assignee: Dr. Karl Thomae GmbH
    Inventors: Norbert Hauel, Annerose Mauz, Jacques van Meel, Michael Entzeroth, Rainer Zimmermann, Willi Diederen